1. Home
  2. KURA vs EDN Comparison

KURA vs EDN Comparison

Compare KURA & EDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

N/A

Current Price

$10.91

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)

EDN

Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)

HOLD

Current Price

$22.71

Market Cap

1.1B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
KURA
EDN
Founded
2014
1992
Country
United States
Argentina
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2015
2007

Fundamental Metrics

Financial Performance
Metric
KURA
EDN
Price
$10.91
$22.71
Analyst Decision
Buy
Analyst Count
11
0
Target Price
$25.56
N/A
AVG Volume (30 Days)
1.8M
47.4K
Earning Date
05-12-2026
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$67,482,000.00
N/A
Revenue This Year
$28.28
$13.19
Revenue Next Year
$106.37
N/A
P/E Ratio
N/A
$16.98
Revenue Growth
25.24
N/A
52 Week Low
$7.36
$14.38
52 Week High
$13.90
$36.70

Technical Indicators

Market Signals
Indicator
KURA
EDN
Relative Strength Index (RSI) 41.50 36.53
Support Level $8.45 $22.09
Resistance Level $11.40 $27.54
Average True Range (ATR) 0.48 0.90
MACD -0.18 -0.13
Stochastic Oscillator 6.75 4.50

Price Performance

Historical Comparison
KURA
EDN

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

About EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)

Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires, mainly for residential, commercial, industrial, and public service.

Share on Social Networks: